American CryoStem Corporation — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d710be48-ea52-4153-b823-54b0656e880d/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-2.9M | 2020-10-01 – 2021-09-30 | evidence 0001019056-22-000053 |
| FY 2020 | $-1.2M | 2019-10-01 – 2020-09-30 | evidence 0001019056-21-000028 |
| FY 2019 | $-1.1M | 2018-10-01 – 2019-09-30 | evidence 0001019056-20-000013 |
| FY 2018 | $-1.5M | 2017-10-01 – 2018-09-30 | evidence 0001019056-19-000013 |
| FY 2017 | $-1.2M | 2016-10-01 – 2017-09-30 | evidence 0001019056-18-000153 |
| FY 2016 | $-1.9M | 2015-10-01 – 2016-09-30 | evidence 0001019056-17-000033 |
| FY 2015 | $-1.4M | 2014-10-01 – 2015-09-30 | evidence 0001019056-16-000990 |
| FY 2014 | $-2.1M | 2013-10-01 – 2014-09-30 | evidence 0001019056-15-000029 |
| FY 2013 | $-2.4M | 2012-10-01 – 2013-09-30 | evidence 0001019056-14-000025 |
| FY 2012 | $-2.4M | 2011-10-01 – 2012-09-30 | evidence 0001019056-13-000045 |
| FY 2011 | $-1.3M | 2010-10-01 – 2011-09-30 | evidence 0001019056-12-000032 |
| FY 2010 | $-32.6k | 2009-10-01 – 2010-09-30 | evidence 0001019056-12-000032 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
American CryoStem Corporation — all facts · Revenue · Operating Income